Home › Gilead stock hits record after hepatitis C drug's success in Europe
 

Keywords :   


Gilead stock hits record after hepatitis C drug's success in Europe

2013-11-22 23:55:24| Biotech - Topix.net

Gilead Sciences said Friday that an advisory committee in the European Union is recommending that its hepatitis C drug Sovaldi receive marketing approval.

Tags: in stock record europe

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
06.07Tropical Storm Beryl Public Advisory Number 29A
06.07Summary for Tropical Storm Beryl (AT2/AL022024)
06.07Atlantic Tropical Weather Outlook
06.07Eastern North Pacific Tropical Weather Outlook
05.07Tropical Storm Beryl Potential Storm Surge Flooding Map
05.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
More »